{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:36:42Z","timestamp":1792420602977,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Cervical cancer is the most preventable and ovarian cancer is the most lethal gynecological cancer. However, in the world, there are disparities in health care performances resulting in differences in the burden of these cancers. The objective of this study was to compare the health-system quality of care and inequities for these cancers using the Quality of Care Index (QCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>The 1990\u20132019 data of the Global Burden of Disease (GBD) was analyzed to extract rates of incidence, prevalence, mortality, Disability-Adjusted Life Years (DALYs), Years of Life Lost (YLL), and Years of healthy life lost due to disability (YLD) of cervical and ovarian cancer. Four indices were developed as a proxy for the quality of care using the above-mentioned rates. Thereafter, a Principal Components Analysis (PCA) was applied to construct the Quality of Care Index (QCI) as a summary measure of the developed indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The incidence of cervical cancer decreased from 1990 to 2019, whereas the incidence of ovarian cancer increased between these years. However, the mortality rate of both cancers decreased in this interval. The global age-standardized QCI for cervical cancer and ovarian cancer were 43.1 and 48.5 in 1990 and increased to 58.5 and 58.4 in 2019, respectively. QCI for cervical cancer and ovarian cancer generally decreased with aging, and different age groups had inequitable QCIs. Higher-income countries generally had higher QCIs for both cancers, but exceptions were also observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Uncovering disparities in cervical and ovarian cancer care across locations, Socio-Demographic Index levels, and age groups necessitate urgent improvements in healthcare systems for equitable care. These findings underscore the need for targeted interventions and prompt future research to explore root causes and effective strategies for narrowing these gaps.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-024-02884-9","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T04:02:07Z","timestamp":1706155327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990\u20132019"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4543-4633","authenticated-orcid":false,"given":"Mohammadreza","family":"Azangou-Khyavy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-7638","authenticated-orcid":false,"given":"Negar","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9853-454X","authenticated-orcid":false,"given":"Javad","family":"Khanali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-3732","authenticated-orcid":false,"given":"Ali-Asghar","family":"Kolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8648-5402","authenticated-orcid":false,"given":"Mohammad-Reza","family":"Malekpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3969-8015","authenticated-orcid":false,"given":"Mahsa","family":"Heidari\u2010Foroozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasserinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9592-2611","authenticated-orcid":false,"given":"Esmaeil","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-7482","authenticated-orcid":false,"given":"Mohsen","family":"Abbasi-Kangevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6028-3303","authenticated-orcid":false,"given":"Seyyed-Hadi","family":"Ghamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sogol","family":"Koolaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Khosravifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar Mohammadi","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-7597","authenticated-orcid":false,"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-4046","authenticated-orcid":false,"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"issue":"12","key":"2884_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"issue":"10159","key":"2884_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1789\u2013858.","journal-title":"The Lancet"},{"key":"2884_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ygyno.2013.12.039","volume":"133","author":"Y Collins","year":"2014","unstructured":"Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol. 2014;133:353\u201361 Academic Press Inc.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2884_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.radonc.2018.03.003","volume":"127","author":"D Cibula","year":"2018","unstructured":"Cibula D, P\u00f6tter R, Planchamp F, Avall-Lundqvist E, Fischerova D, HaieMeder C, et al. The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol. 2018;127(3):404\u201316.","journal-title":"Radiother Oncol"},{"key":"2884_CR5","first-page":"1","volume":"27","author":"A Aminorroaya","year":"2020","unstructured":"Aminorroaya A, Fattahi N, Azadnajafabad S, Mohammadi E, Jamshidi K, Rouhifard Khalilabad M, et al. Burden of non-communicable diseases in Iran: past, present, and future. J Diabetes Metab Disord. 2020;27:1\u20137.","journal-title":"J Diabetes Metab Disord"},{"key":"2884_CR6","unstructured":"WHO\/Europe | European Observatory on Health Systems and Policies - Health system performance comparison. An agenda for policy, information and research . 2013. Available from: https:\/\/www.euro.who.int\/en\/about-us\/partners\/observatory\/publications\/studies\/health-system-performance-comparison.-an-agenda-for-policy,-information-and-research-2013. [Cited 2020 Nov 3]."},{"issue":"10136","key":"2884_CR7","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/S0140-6736(18)30994-2","volume":"391","author":"N Fullman","year":"2018","unstructured":"Fullman N, Yearwood J, Abay SM, Abbafati C, Abd-Allah F, Abdela J, et al. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391(10136):2236\u201371.","journal-title":"Lancet"},{"key":"2884_CR8","doi-asserted-by":"crossref","unstructured":"Khanali J, Malekpour MR, Azangou-Khyavy M, Saeedi Moghaddam S, Rezaei N, Kolahi AA, et al. Global, regional, and national quality of care of gallbladder and biliary tract cancer: a systematic analysis for the global burden of disease study 1990\u20132017. Int J Equity Health. 2021;20(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34922531\/. [Cited 2023 Jan 31].","DOI":"10.1186\/s12939-021-01596-y"},{"key":"2884_CR9","doi-asserted-by":"crossref","unstructured":"Azadnajafabad S, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Rezaei N, Ghasemi E, et al. Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019. Cancer Med. 2023;12(2). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35770711\/. [Cited 2023 Jan 31].","DOI":"10.1002\/cam4.4951"},{"key":"2884_CR10","doi-asserted-by":"crossref","unstructured":"Keykhaei M, Masinaei M, Mohammadi E, Azadnajafabad S, Rezaei N, Saeedi Moghaddam S, et al. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990\u20132017. Exp Hematol Oncol. 2021;10(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33557940\/. [Cited 2023 Jan 31].","DOI":"10.1186\/s40164-021-00198-2"},{"key":"2884_CR11","doi-asserted-by":"crossref","unstructured":"Abbasi-Kangevari M, Ahmadi N, Fattahi N, Rezaei N, Malekpour MR, Ghamari SH, et al. Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990\u20132019. PLoS One. 2022;17(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35913985\/. [Cited 2023 Jan 31].","DOI":"10.1371\/journal.pone.0271284"},{"issue":"7","key":"2884_CR12","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/hep4.1910","volume":"6","author":"SH Ghamari","year":"2022","unstructured":"Ghamari SH, Yoosefi M, Abbasi-Kangevari M, Malekpour MR, Moghaddam SS, Shahin S, et al. Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990\u20132019. Hepatol Commun. 2022;6(7):1764.\u00a0Available from:\u00a0https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/10.1002\/hep4.1910.\u00a0[Cited 2023 Jan 31].","journal-title":"Hepatol Commun"},{"key":"2884_CR13","doi-asserted-by":"crossref","unstructured":"Hanifiha M, Ghanbari A, Keykhaei M, Moghaddam SS, Rezaei N, Zanous MP, et al. Global, regional, and national burden and quality of care index in children and adolescents: A systematic analysis for the global burden of disease study 1990\u20132017. PLoS One. 2022;17(4). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35472096\/. [Cited 2023 Jan 31].","DOI":"10.1371\/journal.pone.0267596"},{"key":"2884_CR14","unstructured":"Quality of Care Index (QCI). Available from: https:\/\/www.protocols.io\/view\/quality-of-care-index-qci-q26g78ym3lwz\/v1. [Cited 2023 Feb 11]."},{"issue":"10258","key":"2884_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1204\u201322.","journal-title":"Lancet (London, England)"},{"issue":"10258","key":"2884_CR16","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223\u201349.","journal-title":"Lancet"},{"key":"2884_CR17","unstructured":"GBD Results Tool | GHDx. Available from: http:\/\/ghdx.healthdata.org\/gbd-results-tool. [Cited 2021 Mar 3]."},{"issue":"10159","key":"2884_CR18","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GA Roth","year":"2018","unstructured":"Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736\u201388.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2884_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.18865\/ed.29.S1.159","volume":"29","author":"AH Mokdad","year":"2019","unstructured":"Mokdad AH, Mensah GA, Krish V, Glenn SD, Miller-Petrie MK, Lopez AD, et al. Global, regional, national, and subnational big data to inform health equity research: Persp ectives from the global burden of disease study 2017. Ethn Dis. 2019;29(Suppl 1):159\u201372.","journal-title":"Ethn Dis"},{"key":"2884_CR20","unstructured":"Methods of Multivariate Analysis - Alvin C. Rencher - Google Books. Available from: https:\/\/books.google.com\/books?hl=en&lr=&id=SpvBd7IUCxkC&oi=fnd&pg=PR5&dq=methods+of+multivariate+analysis+1997+pdf&ots=IvSExAGbD2&sig=rh9zn5tqg6qZMsXYozfJy-c1K1U#v=onepage&q&f=false. [Cited 2020 Nov 3]."},{"issue":"1","key":"2884_CR21","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/S2468-2667(18)30213-5","volume":"4","author":"MW Moses","year":"2019","unstructured":"Moses MW, Pedroza P, Baral R, Bloom S, Brown J, Chapin A, et al. Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016. Lancet Public Health. 2019;4(1):e49-73.","journal-title":"Lancet Public Health"},{"key":"2884_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ijc.30695","volume":"141","author":"AK Mezei","year":"2017","unstructured":"Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, et al. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review. Int J Cancer. 2017;141:437\u201346 Wiley-Liss Inc.","journal-title":"Int J Cancer"},{"key":"2884_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","volume":"389","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women\u2019s cancers: a grand challenge in global health. Lancet. 2017;389:847\u201360 Lancet Publishing Group.","journal-title":"Lancet"},{"key":"2884_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393:169\u201382 Lancet Publishing Group.","journal-title":"Lancet."},{"key":"2884_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.eap.2018.02.001","volume":"58","author":"TA Kolawole Ogundari","year":"2018","unstructured":"Kolawole Ogundari TA. Human capital contribution to economic growth in Sub-Saharan Africa: Does health status matter more than education? Econ Anal Policy. 2018;58:131\u201340.","journal-title":"Econ Anal Policy"},{"issue":"3","key":"2884_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.7888\/juoeh.41.327","volume":"41","author":"Y Matsuura","year":"2019","unstructured":"Matsuura Y, Yoshioka M, Nakata A, Haraga M, Hachisuga T, Mori K. Trends in uterine cervical cancer screening at physical health checkups for company employees in Japan. J UOEH. 2019;41(3):327\u201333.","journal-title":"J UOEH"},{"issue":"3","key":"2884_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10147-018-1350-z","volume":"24","author":"M Kaso","year":"2019","unstructured":"Kaso M, Takahashi Y, Nakayama T. Factors related to cervical cancer screening among women of childrearing age: a cross-sectional study of a nationally representative sample in Japan. Int J Clin Oncol. 2019;24(3):313\u201322.","journal-title":"Int J Clin Oncol"},{"key":"2884_CR28","doi-asserted-by":"crossref","unstructured":"Berkhof J, Bogaards JA, Demirel E, Diaz M, Sharma M, Kim JJ. Cost-Effectiveness of Cervical Cancer Prevention in Central and Eastern Europe and Central Asia. Vaccine. 2013;31. Vaccine.","DOI":"10.1016\/j.vaccine.2012.11.105"},{"key":"2884_CR29","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/S1470-2045(16)30121-8","volume":"17","author":"C Sauvaget","year":"2016","unstructured":"Sauvaget C, Nishino Y, Konno R, Tase T, Morimoto T, Hisamichi S. Challenges in breast and cervical cancer control in Japan. Lancet Oncol. 2016;17:e305-12 Lancet Publishing Group.","journal-title":"Lancet Oncol"},{"issue":"7","key":"2884_CR30","doi-asserted-by":"publisher","first-page":"e0180819","DOI":"10.1371\/journal.pone.0180819","volume":"12","author":"H Sano","year":"2017","unstructured":"Sano H, Goto R, Hamashima C. Does lack of resources impair access to breast and cervical cancer screening in Japan? PLoS One. 2017;12(7):e0180819.","journal-title":"PLoS One"},{"key":"2884_CR31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.mcna.2017.03.006","volume":"101","author":"GF Sawaya","year":"2017","unstructured":"Sawaya GF, Huchko MJ. Cervical cancer screening. Med Clin North Am. 2017;101:743\u201353 W.B. Saunders.","journal-title":"Med Clin North Am"},{"key":"2884_CR32","doi-asserted-by":"crossref","unstructured":"Lew J Bin, Feletto E, Wade S, Caruana M, Kang YJ, Nickson C, et al. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Public Health Res Pract. 2019;29(2). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31384886\/. [Cited 2023 Dec 20].","DOI":"10.17061\/phrp2921913"},{"key":"2884_CR33","doi-asserted-by":"crossref","unstructured":"Pankakoski M, Sarkeala T, Anttila A, Hein\u00e4vaara S. Effectiveness of Cervical Testing in and outside a Screening Program-A Case-Control Study. Cancers (Basel). 2022.;14(21). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36358612\/ [Cited 2023 Dec 20].","DOI":"10.3390\/cancers14215193"},{"issue":"1","key":"2884_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GRF.0000000000000507","volume":"63","author":"EK Hill","year":"2020","unstructured":"Hill EK. Updates in Cervical Cancer Treatment. Clin Obstet Gyneco. 2020;63(1):3\u201311.\u00a0Available from:\u00a0https:\/\/journals.lww.com\/clinicalobgyn\/fulltext\/2020\/03000\/updates_in_cervical_cancer_treatment.3.aspx.\u00a0[Cited 2023 Dec 21].","journal-title":"Clin Obstet Gyneco."},{"key":"2884_CR35","first-page":"1175","volume":"19","author":"G Aimagambetova","year":"2018","unstructured":"Aimagambetova G, Azizan A. Epidemiology of HPV infection and HPV-related cancers in Kazakhstan: a review. Asian Pac J Cancer Prev. 2018;19:1175\u201380 Asian Pacific Organization for Cancer Prevention.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"2884_CR36","first-page":"184","volume":"113","author":"S Dhamija","year":"1993","unstructured":"Dhamija S, Sehgal A, Luthra UK, Sehgal K. Factors associated with awareness and knowledge of cervical cancer in a community: implication for health education programmes in developing countries. J R Soc Promot Health. 1993;113(4):184\u20136.","journal-title":"J R Soc Promot Health"},{"issue":"1","key":"2884_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21106\/ijma.223","volume":"7","author":"PhDS Siziya","year":"2018","unstructured":"Siziya PhDS, Kabalika MBChBC, Mulenga MPHD, Mazaba, MSc ML. Acceptance of Cervical Cancer Screening and its Correlates Among Women of a Peri-Urban High-Density Residential Area in Ndola, Zambia. International Journal of MCH and AIDS (IJMA). 2018;7(1):17\u201327.","journal-title":"International Journal of MCH and AIDS (IJMA)"},{"key":"2884_CR38","doi-asserted-by":"publisher","first-page":"4840762","DOI":"10.1155\/2016\/4840762","volume":"2016","author":"F Ouasmani","year":"2016","unstructured":"Ouasmani F, Hanchi Z, HaddouRahou B, Bekkali R, Ahid S, Mesfioui A. Determinants of patient delay in seeking diagnosis and treatment among moroccan women with cervical cancer. Obstet Gynecol Int. 2016;2016:4840762.","journal-title":"Obstet Gynecol Int"},{"issue":"12","key":"2884_CR39","doi-asserted-by":"publisher","first-page":"e023789","DOI":"10.1136\/bmjopen-2018-023789","volume":"8","author":"O Wegwarth","year":"2018","unstructured":"Wegwarth O, Widschwendter M, Cibula D, Sundstr\u00f6m K, Portuesi R, Lein I, et al. What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. BMJ Open. 2018;8(12):e023789.","journal-title":"BMJ Open"},{"issue":"4","key":"2884_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/01.NURSE.0000553277.03472.d8","volume":"49","author":"BM Ruggles","year":"2019","unstructured":"Ruggles BM, Xiong A, Kyle B. Healthcare coverage in the US and Japan: A comparison. Nursing (Brux). 2019;49(4):56\u201360.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/30893207\/.\u00a0\u00a0[Cited 2023 Dec 20].","journal-title":"Nursing (Brux)"},{"key":"2884_CR41","first-page":"37","volume":"31","author":"K Kokawa","year":"2010","unstructured":"Kokawa K, Takekida S, Kamiura S, Kita M, Enomoto T, Kawaguchi R, et al. The incidence, treatment and prognosis of cervical carcinoma in young women: A retrospective analysis of 4,975 cases in Japan. Eur J Gynaecol Oncol. 2010;31:37\u201343.\u00a0Available from:\u00a0\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/20349779\/.\u00a0[Cited 2020 Nov 4].","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"2884_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brachy.2018.08.016","volume":"18","author":"BA Quinn","year":"2019","unstructured":"Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy. 2019;18(1):29\u201337.","journal-title":"Brachytherapy"},{"key":"2884_CR43","doi-asserted-by":"publisher","unstructured":"Mohammadi E, Aminorroaya A, Fattahi N, Azadnajafabad S, Rezaei N, Farzi Y, Naderimagham S, Rezaei N, Larijani B, Farzadfar F. Epidemiologic pattern of cancers in Iran; current knowledge and future perspective. J Diabetes Metab Disord. 2020;20(1):825\u201329. https:\/\/doi.org\/10.1007\/s40200-020-00654-6.","DOI":"10.1007\/s40200-020-00654-6"},{"issue":"4","key":"2884_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ijc.29438","volume":"137","author":"NG Campos","year":"2015","unstructured":"Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, et al. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. Int J Cancer. 2015;137(4):893\u2013902.","journal-title":"Int J Cancer"},{"key":"2884_CR45","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/14760584.2018.1548282","volume":"17","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev Vaccines. 2018;17:1085\u201391 Taylor and Francis Ltd.","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"2884_CR46","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1002\/ijc.29594","volume":"137","author":"NG Campos","year":"2015","unstructured":"Campos NG, Castle PE, Wright TC, Kim JJ. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage. Int J Cancer. 2015;137(9):2208\u201319.","journal-title":"Int J Cancer"},{"issue":"2","key":"2884_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.bjc.6604462","volume":"99","author":"M Diaz","year":"2008","unstructured":"Diaz M, Kim JJ, Albero G, De Sanjos\u00e9 S, Clifford G, Bosch FX, et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer. 2008;99(2):230\u20138.","journal-title":"Br J Cancer"},{"issue":"43","key":"2884_CR48","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1016\/j.vaccine.2009.07.026","volume":"27","author":"GM Ginsberg","year":"2009","unstructured":"Ginsberg GM, Edejer TTT, Lauer JA, Sepulveda C. Screening, prevention and treatment of cervical cancer-A global and regional generalized cost-effectiveness analysis. Vaccine. 2009;27(43):6060\u201379.","journal-title":"Vaccine"},{"issue":"3","key":"2884_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/AOG.0000000000000981","volume":"126","author":"RD Cress","year":"2015","unstructured":"Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of long-term survivors of epithelial ovarian cancer. Obstet Gynecol. 2015;126(3):491\u20137.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2884_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/gyno.2000.5909","volume":"79","author":"S Greggi","year":"2000","unstructured":"Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, et al. Risk factors for ovarian cancer in central Italy. Gynecol Oncol. 2000;79(1):50\u20134.","journal-title":"Gynecol Oncol"},{"key":"2884_CR51","doi-asserted-by":"crossref","unstructured":"Friebel TM, Domchek SM, Rebbeck TR. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: Systematic review and meta-analysis.\u00a0 J Nat\u00a0 Cancer Inst. 2014;106.\u00a0Oxford University Press.","DOI":"10.1093\/jnci\/dju091"},{"issue":"1","key":"2884_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12885-015-2040-0","volume":"16","author":"B Park","year":"2016","unstructured":"Park B, Park S, Shin HR, Shin A, Yeo Y, Choi JY, et al. Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea. BMC Cancer. 2016;16(1):5.","journal-title":"BMC Cancer"},{"issue":"2","key":"2884_CR53","doi-asserted-by":"publisher","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","volume":"106","author":"B Trabert","year":"2014","unstructured":"Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the ovarian cancer association consortium. J Natl Cancer Inst. 2014;106(2):djt431.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2884_CR54","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/sj.bjc.6600085","volume":"86","author":"M Zhang","year":"2002","unstructured":"Zhang M, Yang ZY, Binns CW, Lee AH. Diet and ovarian cancer risk: a case-control study in China. Br J Cancer. 2002;86(5):712\u20137.","journal-title":"Br J Cancer"},{"issue":"2","key":"2884_CR55","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/ijc.21157","volume":"117","author":"SY Pan","year":"2005","unstructured":"Pan SY, Ugnat AM, Mao Y, Paulse B, Dewar R, Dryer D, et al. Physical activity and the risk of ovarian cancer: a case-control study in Canada. Int J Cancer. 2005;117(2):300\u20137.","journal-title":"Int J Cancer"},{"issue":"55","key":"2884_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","volume":"1","author":"SH Yoon","year":"2016","unstructured":"Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur J Cancer. 2016;1(55):38\u201346.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2884_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.fertnstert.2014.03.041","volume":"102","author":"MS Rice","year":"2014","unstructured":"Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses\u2019 Health Studies. Fertil Steril. 2014;102(1):192-198.e3.","journal-title":"Fertil Steril"},{"issue":"1","key":"2884_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1757-2215-5-13","volume":"5","author":"MS Rice","year":"2012","unstructured":"Rice MS, Murphy MA, Tworoger SS. Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis. J Ovarian Res. 2012;5(1):13.","journal-title":"J Ovarian Res"},{"issue":"3\u20134","key":"2884_CR59","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canep.2009.08.010","volume":"33","author":"A Cabanes","year":"2009","unstructured":"Cabanes A, Vidal E, P\u00e9rez-G\u00f3mez B, Aragon\u00e9s N, L\u00f3pez-Abente G, Poll\u00e1n M. Age-specific breast, uterine and ovarian cancer mortality trends in Spain: Changes from 1980 to 2006. Cancer Epidemiol. 2009;33(3\u20134):169\u201375.","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"2884_CR60","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.AOG.0000231680.58221.a7","volume":"108","author":"JK Chan","year":"2006","unstructured":"Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol. 2006;108(3):521\u20138.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2884_CR61","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3802\/jgo.2013.24.4.342","volume":"24","author":"YC Chiang","year":"2013","unstructured":"Chiang YC, Chen CA, Chiang CJ, Hsu TH, Lin MC, You SL, et al. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol. 2013;24(4):342\u201351.","journal-title":"J Gynecol Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-02884-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-02884-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-02884-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T05:03:25Z","timestamp":1706159005000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-02884-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-02884-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2579470\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"12 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}